Pfizer to buy Anacor Pharma in $5.2 billion deal

(Reuters) - Pfizer Inc will buy Anacor Pharmaceuticals Inc in a deal valued at $5.2 billion, net of cash, for access to Anacor's non-steroidal topical gel to treat eczema.

Read more